189 related articles for article (PubMed ID: 37835371)
1. The Era of Immunotherapy in Hepatocellular Carcinoma: The New Mission and Challenges of Magnetic Resonance Imaging.
Chen Y; Yang C; Sheng L; Jiang H; Song B
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835371
[TBL] [Abstract][Full Text] [Related]
2. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
Gao B; Wang Y; Lu S
Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment.
Zhu J; Xu X; Jiang M; Yang F; Mei Y; Zhang X
Front Oncol; 2023; 13():1145380. PubMed ID: 37051544
[TBL] [Abstract][Full Text] [Related]
4. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
Chen J; Chen X; Li T; Wang L; Lin G
Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
[TBL] [Abstract][Full Text] [Related]
5. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
Luo Y; Liu H; Fu H; Ding GS; Teng F
Front Immunol; 2022; 13():974377. PubMed ID: 36458010
[TBL] [Abstract][Full Text] [Related]
6. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma.
Zhu J; Huang Q; Peng X; Luo C; Liu Z; Liu D; Yuan H; Yuan R; Cheng X
Front Immunol; 2023; 14():1218661. PubMed ID: 37662906
[TBL] [Abstract][Full Text] [Related]
7. A Noninvasive Approach to Evaluate Tumor Immune Microenvironment and Predict Outcomes in Hepatocellular Carcinoma.
Wu J; Liu W; Qiu X; Li J; Song K; Shen S; Huo L; Chen L; Xu M; Wang H; Jia N; Chen L
Phenomics; 2023 Dec; 3(6):549-564. PubMed ID: 38223688
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of an IRF4 risk score to predict prognosis and response to immunotherapy in hepatocellular carcinoma.
Yuan J; Liu Z; Wu Z; Yang J; Yang J
Int Immunopharmacol; 2022 Dec; 113(Pt A):109411. PubMed ID: 36461603
[TBL] [Abstract][Full Text] [Related]
9. Immune cell infiltration and immunotherapy in hepatocellular carcinoma.
Jiang Y; Lin L; Lv H; Zhang H; Jiang L; Ma F; Wang Q; Ma X; Yu S
Math Biosci Eng; 2022 May; 19(7):7178-7200. PubMed ID: 35730302
[TBL] [Abstract][Full Text] [Related]
10. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
Gao S; Zhang L; Wang H
Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
[TBL] [Abstract][Full Text] [Related]
11. Bibliometric study of immunotherapy for hepatocellular carcinoma.
Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
[TBL] [Abstract][Full Text] [Related]
12. Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.
Huang S; Zhang J; Lai X; Zhuang L; Wu J
Front Mol Biosci; 2021; 8():781307. PubMed ID: 35004851
[No Abstract] [Full Text] [Related]
13. An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma.
Wu X; Jin B; Liu X; Mao Y; Wan X; Du S
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10319-10333. PubMed ID: 37273105
[TBL] [Abstract][Full Text] [Related]
14. An imageomics and multi-network based deep learning model for risk assessment of liver transplantation for hepatocellular cancer.
He T; Fong JN; Moore LW; Ezeana CF; Victor D; Divatia M; Vasquez M; Ghobrial RM; Wong STC
Comput Med Imaging Graph; 2021 Apr; 89():101894. PubMed ID: 33725579
[TBL] [Abstract][Full Text] [Related]
15. Progress of MRI Radiomics in Hepatocellular Carcinoma.
Gong XQ; Tao YY; Wu YK; Liu N; Yu X; Wang R; Zheng J; Liu N; Huang XH; Li JD; Yang G; Wei XQ; Yang L; Zhang XM
Front Oncol; 2021; 11():698373. PubMed ID: 34616673
[TBL] [Abstract][Full Text] [Related]
16. Analysis of angiogenesis-related subtypes of hepatocellular carcinoma and tumor microenvironment infiltration feature in hepatocellular carcinoma.
Li W; Wu R; Zhang S; Zhao Y; Li L; Hu Z; Su Q; Mang Y; Zhang X; Dong Y; Zheng K; Ran J; Li L
Clin Transl Oncol; 2023 Jul; 25(7):2099-2115. PubMed ID: 36708372
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-related genes influence immune cell infiltration and immunotherapy response in Hepatocellular Carcinoma.
Gao B; Wang Y; Li C; Lu S
Front Immunol; 2023; 14():1114717. PubMed ID: 36814910
[TBL] [Abstract][Full Text] [Related]
18. Computational Characterizing Necroptosis Reveals Implications for Immune Infiltration and Immunotherapy of Hepatocellular Carcinoma.
Zhu J; Han T; Zhao S; Zhu Y; Ma S; Xu F; Bai T; Tang Y; Xu Y; Liu L
Front Oncol; 2022; 12():933210. PubMed ID: 35875102
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma.
Tang Y; Guo C; Yang Z; Wang Y; Zhang Y; Wang D
Front Immunol; 2022; 13():862527. PubMed ID: 35493471
[TBL] [Abstract][Full Text] [Related]
20. Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6
Li X; Gao Z; Chen J; Feng S; Luo X; Shi Y; Tang Z; Liu W; Zhang X; Huang A; Gao Q; Ke A; Zhou J; Fan J; Fu X; Ding Z
Front Oncol; 2023; 13():1099385. PubMed ID: 37593098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
